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FoxO transcription factors regulate the transcription
of genes that control metabolism, cellular prolifera-
tion, stress tolerance, and possibly life span. A num-
ber of posttranslational modifications within the fork-
head DNA-binding domain regulate FoxO-mediated
transcription. We describe the crystal structures of
FoxO1 bound to three different DNA elements and
measure the change in FoxO1-DNA affinity with acet-
ylation and phosphorylation. The structures reveal
additional contacts and increased DNA distortion
for the highest affinity DNAsite. The flexiblewing 2 re-
gion of the forkhead domain was not observed in the
structures but is necessary for DNA binding, and we
show that p300 acetylation in wing 2 reduces DNA
affinity. We also show that MST1 phosphorylation
of FoxO1 prevents high-affinity DNA binding. The
observation that FoxO-DNA affinity varies between
response elements andwith posttranslationalmodifi-
cations suggests that modulation of FoxO-DNA affin-
ity is an important component of FoxO regulation in
health and misregulation in disease.
INTRODUCTION
FoxO1 belongs to a family of transcription factors that share
a conserved 100 amino acid forkhead box, or winged helix,
DNA-binding domain (DBD). The nomenclature for the more
than 100 members of this gene family has been standardized
such that all members start with Fox (Forkhead box), followed
by a letter to distinguish 17 subfamilies, and a number to distin-
guish individual members (Kaestner et al., 2000) (Figure 1). The
many members of this family are emerging as critical regulators
of development, immunity, metabolism, and cancer. The FoxO
subfamily has been shown to play roles in apoptosis, stress re-
sistance, cell cycle arrest, DNA damage repair response, and
glucose metabolism in mammalian cells (Greer and Brunet,
2005). In addition, recent mouse knockout studies have shown
that FoxOs are tumor suppressors (Paik et al., 2007). FoxO
also represents the closest human homologs of the Caenorhab-
ditis elegans longevity gene daf-16, the downstream target of
daf-2 insulin/IGF-I receptor, and C. elegans sir-2.1 (Kenyon
et al., 1993; Mazet et al., 2003; Tissenbaum and Guarente,Structure 16, 1407–142001). In humans, FoxO activity is regulated by a number of post-
translational modifications (Huang and Tindall, 2007) (Figure 1),
and misregulation of FoxO has been shown to play a role in dis-
eases of aging (Anderson et al., 1998; Borkhardt et al., 1997;
Cheong et al., 2003; Davis et al., 1994; Galili et al., 1993; Hillion
et al., 1997; Hu et al., 2004; Modur et al., 2002; Parry et al., 1994;
Seoane et al., 2004; Sunters et al., 2006).
Previous structures of the FoxA3/HNF-3g, FoxD3/Genesis,
FoxP2, and FoxK1a/ILF-1 forkhead domains bound to their
DNA consensus sequences have revealed a compact three-helix
fold, with the third helix sitting in the major groove of B-form
DNA, and C-terminal b strands projecting along the axis of the
DNA to contact one or both of the adjacent minor grooves (Clark
et al., 1993; Jin et al., 1999; Stroud et al., 2006; Tsai et al., 2006).
Solution structures have also been reported for FoxO4/AFX and
FoxC2/FREAC11 (van Dongen et al., 2000; Weigelt et al., 2001).
The FoxA3/HNF-3g structure, the namesake of the winged helix
domain, was the first reported, and it revealed two well-ordered
loops, or wings, contacting each of the adjacent minor grooves
(Clark et al., 1993). Later structures revealed significant diversity
in DNA binding, particularly in the C-terminal wing 2 region. The
FoxD3/Genesis, FoxK1a/ILF-1, and FoxP2 structures all contain
a combination of a helix and loop in the wing 2 region and medi-
ate divergent interactions with DNA (Jin et al., 1999; Liu et al.,
2002; Stroud et al., 2006; Tsai et al., 2006). Outside of the con-
served DNA-binding motif, forkhead transcription factors also
show important differences in their domain structure, expres-
sion, regulation, and disease association (Myatt and Lam, 2007).
FoxO1was originally namedFKHR, or forkhead in rhabdomyo-
sarcomas, because of its association with a chromosomal trans-
location in alveolar rhabdomyosarcoma (Galili et al., 1993). Later,
daf-16, the C. elegans homolog of FoxO1/FKHR, was character-
ized as a key downstream target in the insulin/IGF-1 signaling
pathway that is required for mutations in the insulin/IGF-1-like re-
ceptordaf-2 to confer increased life span in aC. elegans longevity
model (Gottlieb and Ruvkun, 1994; Kenyon et al., 1993; Larsen
et al., 1995; Ogg et al., 1997). This pathway is well conserved in
humans, where nutrient abundance triggers insulin/IGF-1 recep-
tor signaling that leads to Akt phosphorylation of FoxO1 at Thr24,
Ser256, and Ser319 (Brunet et al., 1999; Rena et al., 1999; Tang
et al., 1999). This phosphorylation causes an interaction with
14-3-3 proteins that localizes FoxO1 to the cytoplasm to block
transcriptional activation by FoxO1 (Brunet et al., 1999). Both
CDK1 and CDK2 have been reported to phosphorylate FoxO1
at Ser249, to regulate subcellular localization of FoxO1 (Huang
et al., 2006; Yuan et al., 2008). The effect of this modification on16, September 10, 2008 ª2008 Elsevier Ltd All rights reserved 1407
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ported to cause nuclear localization and transcriptional activation
(Yuan et al., 2008), and CDK2 reported to cause cytoplasmic
localization and inhibition of FoxO1 (Huang et al., 2006). MST1
kinase has been shown to phosphorylate four sites on FoxO3,
Ser207, Ser213, Ser229, and Ser230, in response to oxidative
stress in neurons (Lehtinen et al., 2006). This phosphorylation is
reported to disrupt FoxO’s interaction with 14-3-3 proteins and
to allownuclear translocation of FoxO,where it initiates apoptotic
cell death (Lehtinen et al., 2006). TheMST1 sites are conserved in
FoxO1 and are also likely targets of MST1 regulation.
In addition to phosphorylation, the DBD of FoxO can be acety-
lated byCBP/p300, and FoxO can be deacetylated by SIRT1 and
SIRT2, which are human homologs of the yeast Sir2 longevity
protein (Brunet et al., 2004; Fukuoka et al., 2003; Jing et al.,
2007; Motta et al., 2004; van der Horst et al., 2004). This provides
an additional level of control over the FoxO transcription factors
and a connection to theSir2model for longevity by calorie restric-
tion. It has been shown that acetylation of three lysines, all within
or near the DBDof FoxO1, reduces the affinity of FoxO1 for target
DNA and increases Akt phosphorylation of FoxO1 (Jing et al.,
2007; Matsuzaki et al., 2005). The biological effects of the acety-
lation state of FoxO are diverse and dependent on both the family
member (FoxO1, FoxO3, FoxO4, and FoxO6) and the cellular
context. Deacetylation of FoxO3 by SIRT1 is associated with re-
pressedFoxO-inducedapoptosis (Mottaet al., 2004); however, in
response to oxidative stress, SIRT1 deacetylation of FoxO3 pro-
motes cell cycle arrest and resistance to oxidative stress (Brunet
et al., 2004). In adipocytes, SIRT2 deacetylation of FoxO1 causes
FoxO1 to suppress adipogenesis through its transcriptional reg-
ulation of cell cycle inhibitors (Jing et al., 2007;Nakaeet al., 2003).
The posttranslational modifications discussed here only repre-
sent the phosphorylation and acetylation sites within or near the
DBD of FoxO1, or amino acids 158–248 in the case of FoxO1.
These sites are interesting from a structural perspective because
theymay regulate FoxO1 activity in different ways. Theymay dis-
rupt or enhance DNA binding directly or they may mediate pro-
tein-protein interactions that regulate FoxO1. Yet another factor
that is reported to be important for regulation of target gene ex-
pression by forkhead transcription factors is variations in affinity
for different DNA response elements. For FoxA transcription fac-
tor in C. elegans, it is reported that high-affinity DNA elements
cause FoxA target genes to be expressed earlier in embryonic
development and low-affinity DNA elements cause delayed
onset of target gene expression (Gaudet and Mango, 2002).
Here, we report structures of the FoxO1 DBD bound to closely
related recognition elements: the insulin response element (IRE)
with the consensus sequence of TT(G/A)TTTTGwas the first rec-
ognition element reported for FoxO1 (Brunet et al., 1999; Guo
et al., 1999; Kops et al., 1999; Tang et al., 1999) and the Daf-
16 family binding element (DBE) with the consensus sequence
of TT(G/A)TTTAC, which is bound by FoxO1 more strongly (Fur-
uyama et al., 2000). We also report a third structure of FoxO1
DBD bound to a higher affinity DBE sequence, called DBE2
here, which reveals that FoxO1 bending of the flanking bases
outside of the eight-base consensus sequence may be impor-
tant for optimal DNA binding by FoxO1. We then measure the
effect of acetylation and phosphorylation on DNA binding affinity
of FoxO1 to provide a structural basis for DNA recognition and
posttranslational regulation of FoxO1.
RESULTS
Structures of FoxO1 DBD Bound to DBE and IRE DNA
Structures of the FoxO1 DBD bound to 16-base-pair DNA con-
taining the DBE recognition sequence of 50-TTGTTTAC-30 or
the IRE recognition sequence of 50-TTGTTTTG-30 were deter-
mined to 2.1 A˚ and 2.2 A˚, respectively (Table 1 and Figure 2).
The structures reveal the expected forkhead, or winged helix,
DNA-binding motif with helix 3 binding in the major groove of
the DNA and the side chains of Asn211 and His215 making all
of thedirect base-specific contacts (Figures 2Band2C; Figure 3).
Side chains of Asn158 andTyr165 from theN terminusof theDBD
andArg225,Ser234,Ser235, andTrp237 fromwing1makephos-
phate contacts to adjacent minor grooves of the DNA (Figure 3).
The2.9 A˚ structure of FoxO1bound to thehigh-affinityDBE2DNA
sequence shows the same interactions around helix 3; however,
it also shows a greater amount of bend in the six base pairs flank-
ing the DBE consensus sequence, where wing 2 is predicted to
make interactions (Figure 2D). Interestingly, unlike previously re-
ported forkhead structures, electron density was not observed
for the C-terminal wing 2 region of the FoxO1 DBD, suggesting
that it is flexible and disordered in the crystals. Given the lack of
sequence homology to other forkhead subfamilies in this region
(Figure 1) and the previously observed structural diversity at the
C terminus of forkhead domains, this finding was not surprising
but required further investigation as described below.
Wing 2 Is Flexible but Essential for DNA Binding
The extent of FoxO1 DBD wing 2 interactions with DNA was not
known at the start of this study. By sequence alignment, wing 2
was predicted to start at Lys245 and possibly extend as far as
Ser256, the target of Akt phosphorylation. To be inclusive of all
posttranslational modification sites, we crystallized and deter-
mined the structure of FoxO1 151–266 bound to the IRE and
DBE2 sequences, but electron density was not observed for res-
idues 242–266. To rule out proteolysis during crystal preparation,
FoxO1/IRE crystals were redissolved in water, and TOF mass
Figure 1. FoxO1 Secondary Structure and Sequence Alignment of Human FoxO1 DBD with Other Forkhead Domains
Residues that undergo phosphorylation or acetylation are marked with a circle or a triangle respectively.
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length protein in the crystals (see Figure S1A available online).
We thenmapped the extent of wing 2 contributions to DNA bind-
ing by preparing four FoxO1 DBD constructs with varying wing 2
lengths andmeasuring DNAbinding using electrophoreticmobil-
ity shift assay (EMSA) (Figures 4A–D). FoxO1 constructs 151–
266 and 151–256 both bound to the IRE and DBE2 sequences
with roughly equal affinity. FoxO1 151–249 also bound to the
DBE2 sequence with roughly equal affinity, whereas binding of
the IRE sequence was reduced by several fold. Surprisingly,
the FoxO1 151–244 construct showed no detectable binding to
IRE or DBE2 DNA, indicating that some or all of wing 2 residues
244–249 are required for FoxO1 to bind DNA. To rule out an
artifact of the EMSA, we also performed the same assay on
151–244 by fluorescence polarization using 151–266 as a posi-
tive control, and we observed the same result (Figure S1B).
These findings suggest that amino acids 244–249 are flexible
but nonetheless important for DNA binding, most likely through
phosphate contacts by Lys245 and Lys248. Previous reports
have suggested that the wing 2 region of FoxO may be more
flexible than the rest of the protein. Specifically, wing 2was found
to bedisordered in a FoxO4DBDsolution structure (without DNA)
byNMR (Weigelt et al., 2001).Molecular Dynamics simulations of
a theoretical FoxO/DNA complex also suggested that wing 2may
be more flexible than the rest of the DBD (Boura et al., 2007).
To lend further support to the hypothesis that wing 2 is the
most flexible part of the FoxO1 DBD even in the presence of
DNA, we performed limited proteolysis of FoxO1 151–266 in the
Table 1. Data Collection and Refinement Statistics for FoxO1/DNA Complexes
FoxO1/IRE DNA FoxO1/DBE1 DNA FoxO1/DBE2 DNA
Native Hg S184C Hg A207C Native Native
Data Collection
Wavelength (A˚) 0.88560 1.54178 1.54178 1.00000 0.97949
Space Group P21212 I222 I222 I222 P32
a, b, c (A˚) 76.06 65.40 65.30 65.52 99.64
102.43 76.17 76.66 76.44 99.64
65.45 102.34 102.36 102.14 98.47
a, b, g () 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 120
Resolution (A˚) 30–2.2 30–3.1 30–3.2 30–2.1 30–2.9
Redundancy 11.0 (9.9) 5.1 (5.0) 6.2 (5.8) 4.8 (4.9) 4.3 (4.3)
Completeness (%) 99.4 (98.1) 99.3 (98.9) 99.8 (99.5) 99.9 (100.0) 99.6 (99.8)
Rsym (%) 6.4 (32.7) 11.8 (31.1) 16.0 (37.3) 7.2 (34.0) 8.8 (32.4)
I/s (I) 39.4 (6.9) 12.8 (6.9) 11.9 (6.3) 20.2 (4.5) 15.7 (4.9)
Phasing Analysis
Resolution (A˚) 30–3.20
Number of sites 2
Figure of merit (FOM) 0.40
Refinement
Resolution (A˚) 30–2.21 30–2.10 30–2.91
Number of reflections 26167 15307 23754
Rwork/Rfree 21.5/24.9 21.1/25.5 26.7/27.6
B factors (A˚2)
All atoms 30.1 39.9 69.0
Protein 26.0 35.9 69.1
DNA 34.1 43.2 68.9
Water 31.7 44.3 54.1
Ions 53.1 60.5 N/A
Ramachandran plot
Most favored 94.9% 92.6% 80.4%
Allowed 5.1% 4.9% 19.6%
Generously allowed 0.0% 2.5% 0.0%
Disallowed 0.0% 0.0% 0.0%
Rms deviations
Bond lengths (A˚) 0.008 0.008 0.007
Bond angles () 1.3 1.3 1.2
Data sets were collected from a single crystal. Values in parentheses are for the highest resolution shell. Rfree was calculated using 10%of the reflection
data chosen randomly and omitted at the start of refinement.
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Structure and Regulation of FoxO1/DNA Complexespresenceof a3-foldexcessofDBE2DNAandsequenced thepro-
teolysis products by N-terminal Edman degradation (Figure S2A–
E). The results confirmed that papain, proteinaseK, and trypsin all
remove C-terminal amino acids preferentially, even in the pres-
ence of DNA. Trypsin also removed N-terminal amino acids
151–157.TOFmassspectrometryof thepapaindigestionproduct
confirmed that papain removes amino acids 245–266, but the
remaining FoxO1 151–244 is stable toward papain. These results
indicate that residues 245–266 are flexible and accessible to pro-
tease digestion, even in the presence of a 3-fold molar excess
DBE2 DNA. These data, and the observation that the S249E
mutation does not affect DNA-binding by Fox01 (see CDK phos-
phorylation), indicate a minimal FoxO1 DBD of residues 158–248
and a short but essential wing 2 comprising residues 245–248.
There also seems to be someDNAbinding contribution fromargi-
nines 250–252 under certain circumstances.
Structural Basis for High-Affinity Binding
of DBE Sequences
When the bases flanking the FoxO consensus sequence are kept
the same, the FoxO1 DBD binds to the DBE1 DNA with 2-fold
greater affinity, compared with the IRE DNA (Figure 5A). High-
resolution structures reveal that the DBE and IRE consensus
sequences are bound with different hydrogen-bonding and
water-mediated interactions through the versatile side chains of
Asn211 and His215 (Figures 2B and 2C; Figure 3). The overall
structural differences between the two FoxO1/DNA complexes
arequite small,withanalignment rmsdof less than0.2 A˚.However,
Figure 2. Structures of FoxO1/DNA Complexes
(A) Representative FoxO1 DBD/DNA complex: 2.1 A˚ structure of FoxO1 bound to the DBE1 sequence. The eight base DBE sequence is in CPK coloring, and
flanking bases are gray.
(B and C) Stereo view of helix 3 interactions with DNA showing the different interactions with IRE (panel b) and DBE (panel c) DNA-mediated by Asn211 and
His215. Electron density shown is from a simulated annealing omit map contoured at 1.0 s around the DNA recognition helix.
(D) Superposition of FoxO1 DBD bound to DBE1 and DBE2 DNAs to illustrate the larger amount of bend in the DNA for the DBE2 structure. FoxO1 DBD bound to
DBE1 is colored in blue and gray. FoxO1 DBD bound to DBE2 is colored in tan and red.
(E–G) The targets of MST1 phosphorylation and their interactions with the phosphate backbone of DNA. Structure shown is FoxO1 DBD/DBE1 DNA. The
interactions are conserved in the FoxO1/IRE DNA structure: panel e, Ser212; panel f, Ser218; and panel g, Ser234 and Ser235.
Figure 3. Schematic Showing FoxO1 DBD
Interactions with IRE and DBE1 DNA
Sequences
(A and B) Differences in hydrogen bonding be-
tween the DBE and IRE sequences are highlighted
in green. Bases that are contacted directly or
through water-mediated interactions are shaded.
Phosphates that are contacted directly or through
water-mediated interactions are highlighted in red.
the network of hydrogen bonds is different
at the protein/DNA interface as a result of
the different arrangement of hydrogen
bond donors and acceptors in the major
groove of the DNA around bases 70 and 80.
In the FoxO1/DBE structure, Asn211
forms bidentate hydrogen bonds with
Ade50 (Figure 2C). His215 in the FoxO1/
DBE structure is protonated with delocal-
ized positive charge between ND1 and
NE2 mediating direct interactions with Thy70, Thy5, and Thy6,
which are within 3.07, 2.90, and 3.07 A˚, respectively, and forming
a water-mediated hydrogen bond to N7 of Gua80. In the FoxO1/
IRE structure, the Asn211 side chain is oriented parallel with the
DNA axis (Figure 2B) and is hydrogen bonding with Ade50 and
Ade60. His215 in the FoxO1/IRE structure is still interacting with
Thy5 and Thy6, and makes a water-mediated hydrogen bond to
Cyt80 in place of Gua80 of the DBE sequence; however, Ade70, re-
placing Thy70 of theDBE sequence, lacks a hydrogen bond accep-
tor for His215. Instead, the hydrogen bond–donating amino group
of Ade70 is 3.47 A˚ away fromHis215 and is unlikely to be contribut-
ing toprotein-DNAaffinity.Webelieve that thisdifference at base70
accounts for the modest 2-fold increased affinity of FoxO1 for the
DBE1 sequence versus the IRE sequence (Figure 5A).
TheDBE2DNAsequencecontains thesame8-baseconsensus
sequence as DBE1 DNA, but the 30 flanking sequence is two
bases longer and has been replaced with the 50-ATTTTG-30
sequence. The 50-NTTT-30 sequence is a high-affinity consensus
sequence for the 30 flanking region enriched by random oligonu-
cleotide selection using mouse FoxO1 DBD, which shares an
identical sequence to human FoxO1 within the DBD (Furuyama
et al., 2000). An analysis of 1387 putative human DBE sequences
in the Database of Transcriptional Start Sites (http://dbtss.hgc.jp)
suggests that thymine-rich 30 flanking sequences are also present
in the human genome.We observed a 5-fold increase in affinity of
FoxO1 DBD for DBE2 DNA versus DBE1 DNA (Figure 5A). The
structure of the FoxO1 DBD/DBE2 DNA complex exhibits
the same binding motif as the DBE1 structure, but in contrast to
Structure 16, 1407–1416, September 10, 2008 ª2008 Elsevier Ltd All rights reserved 1411
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DNA in the 30 flanking region, where wing 2 of FoxO1 is predicted
to make interactions with the DNA minor groove (Figure 2D).
MST1 Phosphorylation Blocks DNA Binding
MST1 kinase is reported to phosphorylate four serines within the
forkhead domains of FoxO1 and FoxO3 to promote FoxO translo-
cation to the nucleus and expression of cell death target genes
(Lehtinen et al., 2006). The FoxO1/DNA structures reported here,
however, reveal that these four serines (Ser212, Ser218, Ser234,
and Ser235) all make either direct or water-mediated hydrogen
bond interactions with the phosphate backbone of the DNA
(Figure 2E–G). On the basis of this observation, we hypothesized
that MST1 phosphorylated FoxO1 would be unable to bind DNA
as a result of steric and electrostatic repulsion of the negatively
charged phosphoserines and the negatively charged DNA back-
bone. To directly measure the effect of MST1 phosphorylation
on DNA affinity, we phosphorylated the FoxO1 DBD with MST1
andpurified the reaction product by gel filtration. TOFmass spec-
trometry confirmed the addition of four phosphates (Figure S3A).
EMSAwas done on theMST1 phosphorylated sample and an un-
Figure 4. Binding of FoxO1 DBD and
Truncation Mutants to Cognate DNA Sites
(A–D) EMSA binding studies to IRE and DBE2
DNA using C-terminally truncated FoxO1 DBD
constructs.
modifiedcontrol tomeasure affinity for the
DBE2 and IRE sequences (Figure 5B). The
assay reveals that MST1-phosphorylated
FoxO1 shows almost no detectable bind-
ing to either DBE2 or IRE DNA for the
1 mM to 0.5 nM FoxO1 concentration
range tested. To rule out an artifact of the
EMSA, we also measured affinity for
DBE2 DNA by fluorescence polarization
using MST1 phosphorylated FoxO1 and
unmodified FoxO1 as a positive control,
and we observed the same result (Fig-
ure S3C). This finding is not necessarily in-
consistentwith the observation thatMST1
activates FoxO; however, it suggests that
there are additional steps, probably in-
volving phosphatase activity, in the path-
way for MST1 activation of FoxO.
CBP/p300 Acetylation Reduces
DNA Binding
Previous studies have investigated the
in vivo effect of FoxO acetylation on
DNA binding (Daitoku et al., 2004). In vitro
DNA-binding assays have alsobeendone
in which CBP/p300 target lysines are mu-
tated to alanine, glutamine, or arginine
(Matsuzaki et al., 2005). These studies
show that removal of the positive charge
at Lys245, 248, and 262 reduces DNA
binding and transcription of FoxO target genes. To more directly
measure the effect of CBP/p300 acetylation on DNA affinity
in vitro, we acetylated the FoxO1 DBD with p300 and purified
the reaction product by gel filtration. We used a combination of
proteolysis and TOFmass spectrometry to confirm that four ace-
tyl groups were added to lysines 245, 248, 262, and 265
(Figure S2B; Figure S4A–C). The fourth acetyl group at Lys265
was not previously reported but is consistent with preference of
CBP/p300 for acetylating KXXK sequences. EMSA was per-
formed on the p300 acetylated sample and an unmodified control
to measure affinity for the DBE2 and IRE sequences (Figure 5C).
The assay reveals that theDNA-binding affinity of p300 acetylated
FoxO1 is reduced by approximately three fold to the DBE2 se-
quence and close to two fold to the IRE sequence. These results
reveal that CBP/p300 acetylation of the FoxO1 DBD does indeed
cause a modest reduction in DNA binding in vitro.
DNA Binding Is Unchanged by Akt or CDK
Phosphorylation
The sites of Akt and CDK1/2 phosphorylation (serines 256 and
249, respectively) are reported to regulate FoxO1 through
1412 Structure 16, 1407–1416, September 10, 2008 ª2008 Elsevier Ltd All rights reserved
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Ser256 by Akt has been shown to regulate FoxO1 by causing
an inhibitory interaction with 14-3-3 proteins. Phosphorylation
of Ser249 is proposed to either disrupt the FoxO1/14-3-3 inter-
action in the cytoplasm or interfere with the adjacent nuclear
localization signal (NLS, arginines 251–253).To test the possi-
bility that phosphorylation of these two sites may also reduce
FoxO1 activity by interfering with DNA binding, we used Akt
kinase to phosphorylate Ser256, and we prepared a S249E
mutant to mimic CDK phosphorylated FoxO1. For the Akt
phosphorylated sample, TOF mass spectrometry was done
to confirm the addition of one phosphate (Figure S5). CDK2
was inactive toward the FoxO1 DBD because of the absence
of the C-terminal regions of FoxO1, amino acids 267–655, as
previously reported (Huang et al., 2006), so the S249E mutant
was made to mimic the modification. EMSA was done on both
samples and on an unmodified control to measure affinity for
the DBE2 and IRE sequences (Figures 5D and E). DNA affinity
for both the Akt phosphorylated FoxO1 and the S249E mutant
were found to be unchanged, compared with unmodified
FoxO1, confirming that these posttranslational modifications
do not affect the DNA-binding activity of FoxO1 under the
conditions tested.
DISCUSSION
DNA recognition bymembers of the 43 human forkhead domain-
containing proteins is diverse in terms of sequence recognition
and structural mode of binding. The C-terminal wing 2 region
Figure 5. Binding of Unmodified and Posttranslationally Modified
FoxO1 DBD to Cognate DNA Sites
(A) EMSA binding studies showing the difference in affinity for FoxO1 151-266
binding to IRE, DBE2 and DBE1 DNA sequences.
(B–E) EMSA results showing the effects of specified FoxO1 151-266 modifica-
tions on binding affinity for IRE and DBE2 DNA sequences.Structure 16, 1407–14of forkhead domains is especially diverse in terms of sequence,
structure, and extent of DNA interactions (Clark et al., 1993; Jin
et al., 1999; Liu et al., 2002; Stroud et al., 2006; Tsai et al.,
2006). Notably, none of the FoxO1/DNA complexes reported
here shows ordered electron density for wing 2, suggesting
that wing 2 is highly flexible and disordered in the crystal lattice.
Further investigation revealed that wing 2 is necessary for high-
affinity DNA binding by FoxO1. This observation suggests that
wing 2 enhances affinity through forming transient and/or multi-
ple nonspecific electrostatic interactions with the phosphate
backbone of the DNA. This hypothesis is supported by the ob-
servation that acetylation of Lys245 and Lys248 in wing 2 by
CBP/p300 reduces DNA-binding affinity (Figure 5c).
Comparison of the FoxO1/DBE and /IRE DNA structures also
reveals new details about how forkhead domains can preferen-
tially bind one sequence over another slightly different sequence.
The more favorable interaction of His215 with the carbonyl oxy-
gen of Thy70 of the DBE DNA sequence likely accounts for most
of the 2-fold difference in affinity between the DBE1 and IREDNA
(Figure 5A). The DBE2 DNA, with thymine rich 30 flanking bases,
exhibited a 5-fold increase in FoxO1 DBD affinity over DBE1,
suggesting that the 30 flanking sequence may be a factor for op-
timal DNA binding by FoxO1. The FoxO1/DBE2 structure reveals
that the 30 flanking region of the DNA is more bent and distorted,
comparedwith the FoxO1/DBE1 structure (Figure 2D). In all three
structures reported here, the DNA forms a pseudo-continuous
helix in the crystal lattice, so it is possible that crystal packing
has influenced the DNA geometry for the structures; however,
the difference in affinity combined with the evidence that wing
2 contributes to DNA binding in this region suggests that the in-
creased A-T content in the 30 flanking region of the DBE2 DNA
may allow for more DNA bending and more optimal interaction
with wing 2 of FoxO1. It has been reported for FoxA transcription
factors that DNA response element affinity can determine the
timing of gene expression in embryonic development (Gaudet
and Mango, 2002). It would be interesting to investigate whether
this holds true for FoxO transcription factors. Genes regulated by
high-affinity DBE sequences may have a different timing of ex-
pression or level of expression, compared with genes regulated
by lower affinity IRE sequences.
Acetylation of the wing 2 region of FoxO by CBP/p300 has
been previously shown to alter transcriptional activity of the pro-
tein (Brunet et al., 2004; Daitoku et al., 2004; Fukuoka et al.,
2003; Jing et al., 2007; Matsuzaki et al., 2005; Motta et al.,
2004; Nakae et al., 2003; van der Horst et al., 2004). Our studies
show that this change in activity canwork, at least in part, via a di-
rect reduction in FoxO1/DNA affinity. However, this decrease in
DNA binding by FoxO1 as a function of wing 2 acetylation is not
nearly as dramatic as the decrease in DNA binding that is caused
byMST1-mediated phosphorylation. In light of this fact, it is pos-
sible that CBP/p300-mediated acetylation of FoxO1 may also
change the transcriptional activity of FoxO through altering pro-
tein-protein interactions that are necessary for FoxO-mediated
transcriptional regulation.
Regulation of FoxO1 activity by Akt, CDK1/2, and MST1
kinases is reported to work by three different mechanisms. Akt
kinase phosphorylation of Ser256was found to have no direct ef-
fect on DNA binding (Figure 5D). This finding is consistent with
regulation through an inhibitory interaction with 14-3-3 proteins16, September 10, 2008 ª2008 Elsevier Ltd All rights reserved 1413
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actions do not extend to Ser256 (Figure 4). CDK2 phosphoryla-
tion of Ser249 was mimicked with a S249E mutant. This mutant
was found to have DNA-binding affinity similar to that of unmod-
ified FoxO1 DBD (Figure 5E). This finding is also consistent with
the proposed mechanism by which phosphorylation of Ser249
regulates FoxO1 activity indirectly by disrupting the FoxO1 inter-
action with 14-3-3 proteins or by blocking the adjacent nuclear
localization signal (Huang et al., 2006; Yuan et al., 2008). Interest-
ingly, MST1 phosphorylation of Ser212, 218, 234, and 235 was
found to almost completely block DNA binding by FoxO1. This
finding is consistent with our observation that the target serines
are making direct or water-mediated contacts to the phosphate
backbone (Figure 2E–G); however, this suggests that the pro-
posed mechanism by which MST1 phosphorylation promotes
nuclear translocation and transcription of FoxO1 target genes
requires an additional step. We propose that dephosphorylation
of serines 212, 218, 234, and 235 occurs before DNA binding
and transcriptional regulation by MST1-restored FoxO1. Alter-
natively, MST1-phosphorylated FoxO1 may participate in tran-
scriptional regulation through association with other regulatory
proteins rather than binding DNA directly.
The diverse biological roles of the FoxO family of transcription
factors and the mechanisms by which FoxO activity is regulated
in the cell remain incompletely understood. Previous reports
have indicated that FoxOs are tumor suppressors andmediators
of longevity as both downstream targets of insulin signaling and
as substrates for Sir2 deacetylase (Biggs et al., 1999; Brunet
et al., 1999, 2004; Daitoku et al., 2004; Fukuoka et al., 2003; Ken-
yon et al., 1993; Motta et al., 2004; Paik et al., 2007; Rena et al.,
1999; Tang et al., 1999; van der Horst et al., 2004). The three
crystal structures reported herein help to explain the structural
basis for DNA recognition by FoxO1 and the factors that contrib-
ute to optimal DNA binding by FoxO1. Our rigorous evaluation of
DNA-binding affinity of directly acetylated and phosphorylated
FoxO1 DBD also provides a more complete understanding of
FoxO1 regulation by posttranslational modification, and how
misregulation of FoxO may lead to disease.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
The gene encoding human FoxO1, amino acids 151–266, was cloned into
a pETDuet-1 vector containing the gene for yeast SMT3, a ubiquitin-like protein
of the SUMO family, in the first multiple cloning site. Overnight expression at
15C in BL21(DE3)LysS (Novagen) yields a 63 histidine-SUMO-FoxO1 fusion
protein. Following lysis and Ni-NTA purification, the His-SUMO tag was re-
movedby incubationwithULP1 (Ubiquitin-like-specificprotease1) at 4Cover-
night. TheFoxO1DBDwas further purified by cation exchange, ammoniumsul-
fate precipitation, and Superdex-75 size exclusion chromatography in 20 mM
HEPES (pH 7.5), 150 mM NaCl, 0.5 mM EDTA, and 2 mM DTT buffer. The
protein was finally concentrated to 8mg/ml and stored at 4C until use. Protein
mutants were generated by site-directed mutagenesis based on the Quick-
Change protocol from Stratagene (Braman et al., 1996). The FoxO1 DBD
truncation constructs and point mutants were purified as described above.
Crystallization
DNA for binding assays and crystallization was purchased from Integrated
DNA Technologies (Coralville, IA). The IRE sequence contains strands 50-CA
AGCAAAACAAACCA-30 and50-TGGTTTGTTTTGCTTG-30. TheDBE1sequence
contains strands 50-CAAGGTAAACAAACCA-30 and 50-TGGTTTGTTTACCTT
G-30. The DBE2 sequence contains strands 50-CAAAATGTAAACAAGA-30 and1414 Structure 16, 1407–1416, September 10, 2008 ª2008 Elsevie50-TCTTGTTTACATTTTG-30. Complementary strands were annealed in 20 mM
HEPES (pH7.5) and 50mMNaCl buffer by heating to 80C for 10min and slowly
cooling to room temperature for 3 hr. FoxO1-DNA complexes for crystallization
were prepared by mixing concentrated FoxO1 DBD, amino acids 151–266 for
the IRE andDBE2 structures and 151–249 for the DBE1 structure, with concen-
trated, annealed DNA in a 1:1.2molar ratio. The final concentration of FoxO1 for
crystallization was 5 mg/ml. Crystals of FoxO1 DBD/IRE DNA were grown by
hanging drop vapor diffusion in 4 days at 4C using a well solution containing
50 mM sodium cacodylate (pH 6.8), 0.2 M NH4Cl, 0.01 M CaCl2, and 30%
PEG4,000.Crystals of FoxO1DBD/DBE1DNAweregrownunder thesamecon-
ditions except with 50 mM HEPES (pH 7.9) and 22% PEG 4,000. Crystals of
FoxO1 DBD/DBE2 DNA were also grown under the same conditions except
with 50 mM sodium cacodylate (pH 6.4) and 21% PEG 4,000. All crystals were
frozen in well solution plus 25% glycerol for cryoprotection. The IRE-containing
crystals formed in thespacegroupP21212, theDBE1-containingcrystals formed
in the space group I222, and the DBE2-containing crystals formed in the space
group P32. Soaking in mercury chloride changed cysteine mutant FoxO1 DBD/
IRE crystals from the P21212 space group to the I222 space group with approx-
imately the same unit cell dimensions.
Data Collection and Structure Determination
Native data sets were collected at the NSLS X6A and APS 23ID-B beamlines.
Mercury-soaked FoxO1 S184C and A207C bound to IRE DNA data sets were
collected on a Rigaku Raxis-IV home source. Data were processed using
HKL2000 (Otwinowski and Minor, 1997). Single Isomorphous Replacement
(SIR) was performed with Solve and Resolve (Terwilliger, 2000; Terwilliger
and Berendzen, 1999) to find two mercury sites in a FoxO1 DBD S184C mu-
tant/IRE DNA crystal. A mercury-soaked A207C mutant data set was initially
set as the native data set, since mercury soaking changed the space group
to I222, and the native data set was in the P21212 space group. Initial model
building with Coot (Emsley and Cowtan, 2004) and refinement with CNS
(Brunger et al., 1998) yielded a low-resolution structure that was used for mo-
lecular replacement into the higher resolution native P21212 (IRE DNA) and P32
(DBE2 DNA) space groups using Phaser (Read, 2001; Storoni et al., 2004). The
DBE1 DNA structure, also in the I222 space group, was solved later using
Phaser and the FoxO1 DBD/IRE DNA complex as a search model. Models
were initially refined with simulated annealing, energy minimization, and group
B-factor refinement. For later stages of refinement, ions and solvent molecules
were added to the model, and individual atomic B-factors were refined. The
final model was checked for errors against a simulated annealing omit map.
Refinement of all three structures resulted in models with excellent statistics
and geometries (Table 1). Figures were prepared using PyMOL (DeLano Scien-
tific, Palo Alto, CA).
MST1 Phosphorylation
Human full-length MST1 kinase was amplified and cloned into a pACHis-tev
baculoviral transfer vector. Recombinant viruses were selected, amplified,
and harvested in Sf9 cells, as described elsewhere (Hutchison et al., 1998).
Cells were lysed in 50 mM TRIS (pH 8.0), 400 mM NaCl, 2 mM imidazole,
and 1 mM b-mercaptoethanol supplemented with protease inhibitors. The
clarified supernatant was loaded onto Ni-NTA agarose, washed, and eluted
with 25 mMHEPES (pH 7.5), 100 mMNaCl, and 200 mM imidazole. The eluted
protein was further purified by Superdex-200 size exclusion chromatography
in 25mMHEPES (pH 7.5) and 100mMNaCl. The eluted fractions were pooled,
concentrated to 2 mg/ml, and flash frozen until use. MST1 was incubated with
the FoxO1 DBD (151–266) in a 1:10 ratio (MST/FoxO1) at 30C for 4 hr in buffer
containing 20 mM TRIS (pH 7.5), 5 mMMgCl2, and 2 mM ATP. A control sam-
ple was also incubated at 30C for 4 hr in the absence of MST1 or ATP. After
4 hr, the sample was put on ice for 10 min and then injected onto a Superdex-
75 size exclusion column to purify the FoxO1 DBD from theMST1 and the ATP.
Purified FoxO1 was then concentrated and analyzed by MALDI-TOF mass
spectrometry to confirm phosphorylation. The mass of the largest peak corre-
sponded to the addition of four phosphates. Species corresponding to three
and five phosphates were also observed (Figure S3A).
p300 Acetylation
p300 (a gift from Xin Liu, Ling Wang, Philip Cole, and R.M.) was incubated with
the FoxO1 DBD (151–266) in a 1:20 ratio (p300/FoxO1) at 30C for 3 hr in bufferr Ltd All rights reserved
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BSA, and 3 mM Acetyl-CoA. A control sample was also incubated at 30C
for 3 hr with the same buffer conditions but with p300 absent. After 3 hr, the
sample was put on ice for 10 min and then injected onto a Superdex-75 size
exclusion column to purify the FoxO1 DBD from the p300 and the Acetyl
CoA. Purified FoxO1 was then concentrated and analyzed by MALDI-TOF
mass spectrometry to confirm acetylation. Results indicated one distinct spe-
cies with an increased mass of 172 Da or approximately four acetyl groups
(Figure S4A). A combination of papain digestion, MALDI-TOF mass spectrom-
etry, and N-terminal sequencing was used to confirm that the acetyl groups
were added to the C terminus of FoxO1 (amino acids 245–266) (Figures S2B
and S4C).
Akt Phosphorylation
Akt1 (PKB a) was purchased (Biomol International, SE-416) and incubated with
the FoxO1 DBD (151–266) at 30C for 3 hr in buffer containing 25 mM MOPS
(pH 7.2), 12.5 mM b-glycerophosphate, 25 mM MgCl2, 5 mM EGTA, 2 mM
EDTA, 0.4 mM DTT, and 2 mM ATP. A control sample was also incubated at
30C for 3 hr with the same buffer conditions but with Akt absent. After 3 hr,
the sample was put on ice for 10 min and then injected onto a Superdex-75
size exclusion column to purify the FoxO1 DBD from the Akt and the ATP. Pu-
rified FoxO1 was then concentrated and analyzed by MALDI-TOF mass spec-
trometry to confirm phosphorylation. Results showed one distinct species with
an increased mass of 90 Da or approximately one phosphate group
(Figure S5A).
DNA-Binding Assays
EMSAs were done with biotinylated DNA duplexes (Integrated DNA Technol-
ogies, Coralville, IA) and developed with a chemiluminescent nucleic acid de-
tection kit (Pierce 89880). Briefly, a serial dilution of FoxO1 protein was pre-
pared to give a final concentration range of 1 mM to 0.5 nM FoxO1. FoxO1
serial dilutions were each equilibrated at room temperature with 1 nM DNA
for 30 min in binding buffer containing 20 mM TRIS (pH 8.0), 50 mM KCl,
5% glycerol, 2 mM DTT, 0.2 mM EDTA, 2 mM MgCl2, 0.1 mg/mL BSA, and
1 ng/uL poly dI$dC. The equilibrated mixture was loaded onto a 6% DNA re-
tardation gel (Invitrogen) in 0.53 TRIS-borate-EDTA (TBE) and run at 100 V
for 1 hr at 4C. The gel was blotted onto a Biodyne B (Invitrogen) membrane
at 380 mA for 1 hr in 0.53 TBE at 4C. The blotted DNA was cross-linked to
themembrane using a Stratagene cross-linker. Themembrane was developed
according to the nucleic acid detection protocol from Pierce. Films were then
exposed, developed, and scanned. All assays were done in duplicate. Appar-
ent Kd values were determined by measuring shifted band intensity with
ImageJ (from the NIH; http://rsb.info.nih.gov/ij/) and fitting a plot of intensity
versus Log[FoxO1] to one-site competitive binding in GraphPad Prism
software.
ACCESSION NUMBERS
Coordinates for the FoxO1 DBD/IRE, /DBE1, and /DBE2 DNA complexes have
been deposited in the Protein Data Bank with accession codes 3COA, 3CO6,
and 3CO7, respectively.
SUPPLEMENTAL DATA
Supplemental data include five figures and can be found with this article online
at http://www.structure.org/cgi/content/full/16/9/1407/DC1/.
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